Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of ZD6474 (Vandetanib) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma

NCT00441142 is registered in ClinicalTrials.gov with Patrick Y. Wen, MD as lead sponsor.

NCT NCT00441142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00441142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of ZD6474 (Vandetanib) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
Lead sponsor
Patrick Y. Wen, MD
Phase
Phase 1/2
Overall status
Completed
Start date
May 25, 2007
Completion date
October 10, 2017
Enrollment
119 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, gliosarcoma